SCG Cell Therapy Launches Global Manufacturing and R&D Center in Singapore with Automated System
Singapore-based SCG Cell Therapy Pte. Ltd has announced the initiation of its global manufacturing and...
Zennova Pharmaceutical Group Secures RMB 100 Million in Series B Financing for Commercial Manufacturing and R&D
China-based Zennova Pharmaceutical Group has reportedly raised close to RMB 100 million (USD 13.9 million)...
Ocumension Therapeutics’ OT-101-S Myopia Treatment Accepted for CDE Review
Chinese ophthalmology specialist Ocumension Therapeutics (HKG: 1477) has announced that the Center for Drug Evaluation...
Beijing Intellectual Property Court Upholds Validity of Novartis’ Entresto Patent
The Beijing Intellectual Property Court (BIPC) has issued a judgment that reaffirms the validity and...
Johnson & Johnson Reports 7.5% YOY Sales Growth in Q2 2023, Driven by Pharma and Devices
Johnson & Johnson (J&J; NYSE: JNJ) has published its financial results for the second quarter...
Sartorius Expands Global Footprint with New Cell Culture Facility in Puerto Rico
Germany-based laboratory services firm Sartorius has expanded its operations with the opening of a new...
Sandoz Plans USD 90 Million Biosimilar Development Center in Slovenia by 2026
The Sandoz unit of Switzerland-based Novartis (NYSE: NVS) has announced plans to construct a biosimilar...
Johnson & Johnson Files Lawsuit Against US Government’s Drug Pricing Negotiation Authority
United States-based Johnson & Johnson (J&J, NYSE: JNJ) has filed a lawsuit this week, challenging...
GSK Partners with LimmaTech for Further Development of Quadrivalent Shigellosis Vaccine
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has licensed its quadrivalent bioconjugate shigellosis vaccine candidate...
Abbott Reports Q2 2023 Revenue Growth Exceeding Estimates Despite COVID-19 Dip
US-based life sciences firm Abbott (NYSE: ABT) has released its financial results for the second...
Jiangsu Simcere Pharmaceutical Gets NMPA Approval for Quviviq, Anti-Insomnia Drug
Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has announced the receipt of clinical trial approval...
Livzon Pharmaceutical Secures Licensing Agreement for Synergy Pharma’s HHT120 in Greater China
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with fellow Chinese...
Alibaba Health and Daiichi Sankyo Partner to Innovate in Digital Healthcare Services
China’s Alibaba Health Information Technology Ltd (HKG: 0241) has entered into a strategic partnership with...
Pfizer’s GBS Vaccine Candidate GBS6 Shows Promise in Phase II Maternal Immunization Study
Pfizer (NYSE: PFE) has this week published the Phase II data for its Group B...
US Merger Guidelines Updated: Public Comment Sought on Antitrust Law Changes
The United States has published an update to its merger and acquisition guidelines, seeking public...
Merck and Telix Pharmaceuticals Initiate Phase I Study for CAIX-Expressing Tumors Therapy
A Phase I study assessing the combination of German-major Merck’s (NYSE: MRK) DNA-PK inhibitor, peposertib,...
Janssen’s Sirturo (Bedaquiline) Expands Indication to Include Adolescents with MDR-TB
The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) has announced that the National...
Chongqing Zhifei Biological Launches Phase I Clinical Trial for Group B Meningococcal Vaccine
Chongqing Zhifei Biological Co., Ltd (SHE: 300122) has announced the commencement of a Phase I...
Chipscreen Pharmaceutical’s Epidaza Granted Priority Status for DLBCL Treatment in China
The Center for Drug Evaluation (CDE) website has announced that Shenzhen Chipscreen Biosciences Co., Ltd’s...
HutchMed’s Elunate-Tyvyt Combo Receives Breakthrough Therapy Designation in China for Endometrial Cancer
HutchMed (China) Ltd (NASDAQ: HCM, HKG: 0013) has announced that the combination of Elunate (fruquintinib)...